Literature DB >> 14638922

Sympathetic nerve activity is inappropriately increased in chronic renal disease.

Inge H H T Klein1, Gerry Ligtenberg, Jutta Neumann, P Liam Oey, Hein A Koomans, Peter J Blankestijn.   

Abstract

The hypothesis that in hypertensive patients with renal parenchymal disease sympathetic activity is "inappropriately" elevated and that this overactivity is a feature of renal disease and not of a reduced number of nephrons per se is addressed. Fifty seven patients with renal disease (various causes, no diabetes, all on antihypertensive medication) were studied, age range 18 to 62, creatinine clearance 10 to 114 ml/min per 1.73 m(2). Antihypertensives were stopped, but diuretics were allowed, to prevent overhydration. Matched control subjects were also studied. The effect of changes in fluid status was examined in seven patients while on and after stopping diuretics and in eight control subjects while on low- and high-sodium diet. Seven kidney donors were studied before and after unilateral nephrectomy. Sympathetic activity was quantified as muscle sympathetic nerve activity (MSNA) in the peroneal nerve. Mean arterial pressure, MSNA, and plasma renin activity were higher in patients than in control subjects, respectively (115 +/- 12 and 88 +/- 11 mmHg, 31 +/- 15 and 18 +/- 10 bursts/min, and 500 [20 to 6940] and 220 [40 to 980] fmol/L per s; P < 0.01 for all items). Extracellular fluid volume (bromide distribution) did not differ. Seven patients were studied again after stopping diuretics. MSNA decreased from 34 +/- 18 to 19 +/- 18 bursts/min (P < 0.01). Eight healthy subjects were studied during low- and high-sodium diet. MSNA was 26 +/- 12 and 13 +/- 7 bursts/min (P < 0.01). The curves relating extracellular fluid volume to MSNA were parallel in the two groups but shifted to a higher level of MSNA in the patients. In the kidney donors, creatinine clearance reduced by 25%, but MSNA was identical before and after donation. It is concluded that in hypertensive patients with renal parenchymal disease, sympathetic activity is inappropriately high for the volume status and that reduction of nephron number in itself does not influence sympathetic activity.

Entities:  

Mesh:

Year:  2003        PMID: 14638922     DOI: 10.1097/01.asn.0000098687.01005.a5

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  43 in total

Review 1.  Premise, promise, and potential limitations of invasive devices to treat hypertension.

Authors:  Elizabeth A Martin; Ronald G Victor
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

Review 2.  Sympathetic hyperactivity in chronic kidney disease: pathophysiology and (new) treatment options.

Authors:  Eva E Vink; Rosa L de Jager; Peter J Blankestijn
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

3.  Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease.

Authors:  Guido Grassi; Gino Seravalle; Lorenzo Ghiadoni; Giovanni Tripepi; Rosa Maria Bruno; Giuseppe Mancia; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-22       Impact factor: 8.237

Review 4.  The role of the kidney and the sympathetic nervous system in hypertension.

Authors:  Philip Thomas; Indranil Dasgupta
Journal:  Pediatr Nephrol       Date:  2014-03-08       Impact factor: 3.714

5.  Cerebral blood flow regulation in end-stage kidney disease.

Authors:  Justin D Sprick; Joe R Nocera; Ihab Hajjar; W Charles O'Neill; James Bailey; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-28

Review 6.  Nutraceuticals as a potential adjunct therapy toward improving vascular health in CKD.

Authors:  Nicholas T Kruse
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

7.  Exercise pressor response and arterial baroreflex unloading during exercise in chronic kidney disease.

Authors:  Jeanie Park; Arshed A Quyyumi; Holly R Middlekauff
Journal:  J Appl Physiol (1985)       Date:  2012-12-13

Review 8.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 9.  Management of hypertension in chronic kidney disease.

Authors:  Raymond R Townsend; Sandra J Taler
Journal:  Nat Rev Nephrol       Date:  2015-07-28       Impact factor: 28.314

10.  Cardiac autonomic neuropathy as a predictor of deterioration of the renal function in normoalbuminuric, normotensive patients with type 2 diabetes mellitus.

Authors:  Yong Kyun Kim; Jung Eun Lee; Yoon Goo Kim; Dae Joong Kim; Ha-Young Oh; Chul Woo Yang; Kwang-Won Kim; Wooseong Huh
Journal:  J Korean Med Sci       Date:  2009-01-28       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.